Generic use of antipsychotics in Medicaid

HB 4984 modifies West Virginia's prior authorization rules for FDA-approved antipsychotic medications. It requires the Bureau for Medical Services to use an electronic portal for all prior authorization requests, including clear instructions, real-time status updates, and a quarterly updated science-based list of required authorizations. The bill mandates responses within five business days (or two days for urgent cases) and requires clear disclosure about step therapy protocols on forms. This directly affects healthcare providers submitting requests and patients needing these medications, aiming to streamline the approval process for antipsychotics.